Affect Therapeutics
PrivateLast Round
Series B
Nov 5, 2025
Total Funding Raised
$49M
Company Overview
Affect Therapeutics is a digital health company that offers a smartphone application for addiction treatment, utilizing mobile technology and reward systems to enhance patient engagement and support recovery from alcohol and drug dependence.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts, Freemium, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affect Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Affect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2025 | ||||
| Series A | Jul 12, 2023 | ||||
| Seed | Aug 31, 2021 | ||||
| Seed | Apr 21, 2021 |
Affect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Seed, Series A |
| ARTIS Ventures | Series B, Series A |
| LifeArc Ventures | Series B, Series A |
| Kapor Capital | Seed |
| Acumen | Seed |
| Samsung Next | Series A |
| What If Ventures | Series A |
Affect Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Affect Therapeutics's valuation, stock price, and market status.
